[1]
|
张学军. 皮肤性病学[M]. 第9版. 北京: 人民卫生出版社, 2018: 133-134.
|
[2]
|
全国银屑病流行调查组, 邵长庚, 张国威, 包寅德, 蒋仲元, 韩国柱, 顾恒. 全国1984年银屑病流行调查报告[J]. 皮肤病与性病, 1989(1): 60-72.
|
[3]
|
Ding, X., Wang, T., Shen, Y., et al. (2012) Prevalence of Psoriasis in China: A Population-Based Study in Six Cities. European Journal of Dermatology, 22, 663-667. https://doi.org/10.1684/ejd.2012.1802
|
[4]
|
Deng, Y., Chang, C. and Lu, Q. (2016) The Inflammatory Response in Psoriasis: A Comprehensive Review. Clinical Reviews in Allergy & Immunology, 50, 377-389. https://doi.org/10.1007/s12016-016-8535-x
|
[5]
|
林立, 王姗姗, 杨素清. 中药调节银屑病相关分子研究进展[J]. 中国中医药信息杂志, 2022, 29(5): 147-152.
https://doi.org/10.19879/j.cnki.1005-5304.202108469
|
[6]
|
朱雨雨, 宋承霖, 孙洋. 银屑病发病机制及药物调控研究进展[J]. 药学学报, 2020, 55(7): 1393-1400.
https://doi.org/10.16438/j.0513-4870.2019-1071
|
[7]
|
Oppmann, B., Lesley, R., Blom, B., et al. (2000) Novel p19 Protein Engages IL-12p40 to Form a Cytokine, IL-23, with Biological Activities Similar as Well as Distinct from IL-12. Immunity, 13, 715-725.
https://doi.org/10.1016/S1074-7613(00)00070-4
|
[8]
|
Haniffa, M., Gunawan, M. and Jardine, L. (2015) Human Skin Dendritic Cells in Health and Disease. Journal of Dermatological Science, 77, 85-92. https://doi.org/10.1016/j.jdermsci.2014.08.012
|
[9]
|
Bloch, Y., Bouchareychas, L., Merceron, R., et al. (2018) Structural Activation of Pro-Inflammatory Human Cytokine IL-23 by Cognate IL-23 Receptor Enables Recruitment of the Shared Receptor IL-12Rβ1. Immunity, 48, 45-58.e6.
https://doi.org/10.1016/j.immuni.2017.12.008
|
[10]
|
Gooderham, M.J., Papp, K.A. and Lynde, C.W. (2018) Shifting the Focus—The Primary Role of IL-23 in Psoriasis and Other Inflammatory Disorders. Journal of the European Acade-my of Dermatology and Venereology, 32, 1111-1119.
https://doi.org/10.1111/jdv.14868
|
[11]
|
李清林, 章煌杰, 葛明华, 等. 基于Th17/Treg平衡和IL-23/IL-17炎症轴探讨淫羊藿总黄酮防治桥本甲状腺炎的作用机制[J]. 中华中医药学刊, 2021, 39(8): 71-77+266-267. https://doi.org/10.13193/j.issn.1673-7717.2021.08.016
|
[12]
|
王宁, 张卫宁, 陈雨婕, 等. IL-23/IL-17炎症轴与炎症性肠病的关系研究进展[J]. 细胞与分子免疫学杂志, 2021, 37(3): 271-277. https://doi.org/10.13423/j.cnki.cjcmi.009167
|
[13]
|
Hou, Y., Zhu, L., Tian, H., et al. (2018) IL-23-Induced Macro-phage Polarization and Its Pathological Roles in Mice with Imiquimod-Induced Psoriasis. Protein & Cell, 9, 1027-1038. https://doi.org/10.1007/s13238-018-0505-z
|
[14]
|
Martin, D.A., Towne, J.E., Kricorian, G., et al. (2013) The Emerging Role of IL-17 in the Pathogenesis of Psoriasis: Preclinical and Clinical Findings. Journal of Investigative Dermatology, 133, 17-26.
https://doi.org/10.1038/jid.2012.194
|
[15]
|
Cătană, C.S., Berindan Neagoe, I., Cozma, V., Magdaş, C., Tăbăran, F. and Dumitraşcu, D.L. (2015) Contribution of the IL-17/IL-23 Axis to the Pathogenesis of Inflammatory Bowel Disease. World Journal of Gastroenterology, 21, 5823-5830. https://doi.org/10.3748/wjg.v21.i19.5823
|
[16]
|
Fitch, E., Har-per, E., Skorcheva, I., Kurtz, S.E. and Blauvelt, A. (2007) Pathophysiology of Psoriasis: Recent Advances on IL-23 and Th17 Cytokines. Current Rheumatology Reports, 9, 461-467. https://doi.org/10.1007/s11926-007-0075-1
|
[17]
|
Lowes, M.A., Russell, C.B., Martin, D.A., Towne, J.E. and Krueger, J.G. (2013) The IL-23/T17 Pathogenic Axis in Psoriasis Is Amplified by Keratinocyte Responses. Trends in Immunology, 34, 174-181.
https://doi.org/10.1016/j.it.2012.11.005
|
[18]
|
Tonel, G. and Conrad, C. (2009) Interplay between Keratinocytes and Immune Cells—Recent Insights into Psoriasis Pathogenesis. The International Journal of Biochemistry & Cell Biology, 41, 963-968.
https://doi.org/10.1016/j.biocel.2008.10.022
|
[19]
|
Yawalkar, N., Karlen, S., Hunger, R., Brand, C.U. and Braathen, L.R. (1998) Expression of Interleukin-12 Is Increased in Psoriatic Skin. Journal of Investigative Dermatology, 111, 1053-1057.
https://doi.org/10.1046/j.1523-1747.1998.00446.x
|
[20]
|
张伟晴, 沙日耐, 姜萱璟, 等. 银屑病免疫治疗靶点研究进展[J]. 基因组学与应用生物学, 2021, 40(Z4): 3853- 3862. https://doi.org/10.13417/j.gab.040.003853
|
[21]
|
Lee, E., Trepicchio, W.L., Oestreicher, J.L., et al. (2004) Increased Expression of Interleukin 23 p19 and p40 in Lesional Skin of Patients with Psoriasis Vulgaris. Journal of Experimental Medicine, 199, 125-130.
https://doi.org/10.1084/jem.20030451
|
[22]
|
Kastelein, R.A., Hunter, C.A. and Cua, D.J. (2007) Discovery and Bi-ology of IL-23 and IL-27: Related but Functionally Distinct Regulators of Inflammation. Annual Review of Immunology, 25, 221-242.
https://doi.org/10.1146/annurev.immunol.22.012703.104758
|
[23]
|
乔菊, 高祎濛, 李峰, 等. 银屑病患者外周血TNF-α、IL-17A、IL-23、IL-36γ表达水平及临床意义[J]. 中国皮肤性病学杂志, 2019, 33(3): 280-284. https://doi.org/10.13735/j.cjdv.1001-7089.201806035
|
[24]
|
赵京霞, 底婷婷, 王燕, 等. IL-23/IL-17炎症轴在咪喹莫特诱导的小鼠银屑病样皮肤损害中的作用[J]. 中国病理生理杂志, 2013, 29(6): 1086-1094.
|
[25]
|
马彦巧, 陈积, 李磊, 等. 白细胞介素-23抑制剂治疗银屑病的研究进展[J]. 中国新药杂志, 2018, 27(8): 899-904.
|
[26]
|
刘小扬, 蔡林, 张建中. 白细胞介素-17抑制剂治疗银屑病的效能及应用[J]. 临床皮肤科杂志, 2021, 50(3): 173-177. https://doi.org/10.16761/j.cnki.1000-4963.2021.03.014
|
[27]
|
李明洙, 钟伟章. 白细胞介素(IL)-12/23、IL-17和IL-23抑制剂治疗中度至重度斑块状银屑病的疗效和安全性的系统评价[J]. 临床皮肤科杂志, 2022, 51(1): 11-18. https://doi.org/10.16761/j.cnki.1000-4963.2022.01.005
|
[28]
|
吴先伟, 邓秀娥, 汪舰笛, 等. 白芍总苷对老年中重度斑块状银屑病患者T淋巴细胞亚群及相关细胞因子的影响[J]. 中国中西医结合皮肤性病学杂志, 2022, 21(4): 310-313.
|
[29]
|
Gaelle, E.T.T., 江从军. 雷公藤多苷对寻常型银屑病患者外周血Th17/Treg相关细胞因子的影响[J]. 中华全科医学, 2019, 17(8): 1272-1274. https://doi.org/10.16766/j.cnki.issn.1674-4152.000919
|
[30]
|
行敏, 任宏伟, 屈慧明, 等. 寻常型银屑病患者血清中IL-17的表达及紫草素对IL-17刺激HaCaT细胞分泌IL-6和IL-23的影响[J]. 吉林大学学报(医学版), 2017, 43(5): 958-962. https://doi.org/10.13481/j.1671-587x.20170519
|
[31]
|
王雾, 杨梅, 蒋梦雅, 等. 人参皂苷CK对咪喹莫特诱导小鼠银屑病的治疗作用[J]. 中国药理学通报, 2021, 37(1): 31-37.
|
[32]
|
孙丹, 闫小宁, 耿蒙利, 等. 银屑平片对咪喹莫特诱导银屑病样模型小鼠IL-17、IL-23、PPARγ表达的影响[J]. 中国中医药信息杂志, 2022, 29(4): 64-68. https://doi.org/10.19879/j.cnki.1005-5304.202107120
|
[33]
|
钟淇滨, 祝曙光, 陆少君, 等. 和厚朴酚对咪喹莫特诱导小鼠银屑病的干预作用[J]. 中国药理学通报, 2018, 34(5): 626-631.
|
[34]
|
周海锋. 苦豆碱通过调控IL-23/Th17轴和促进Treg稳定性缓解IMQ诱导的小鼠银屑病样皮炎[D]: [硕士学位论文]. 武汉: 华中科技大学, 2019. https://doi.org/10.27157/d.cnki.ghzku.2019.001829
|
[35]
|
热比姑丽•伊斯拉木, 艾西木江•热甫卡提, 阿布都吉力力•阿布都艾尼, 等. 土大黄对银屑病小鼠皮肤组织转化生长因子-β1及神经纤维蛋白-1表达的影响[J]. 中国药业, 2020, 29(3): 20-24.
|
[36]
|
李皓月, 李超然, 王远红, 等. 银屑病中医文献简述[J]. 中国中医基础医学杂志, 2019, 25(9): 1331-1334.
https://doi.org/10.19945/j.cnki.issn.1006-3250.2019.09.050
|
[37]
|
王丽, 方玉甫, 周国秀, 等. 基于IL-23/Th17探讨清营汤治疗银屑病血热证的临床疗效及作用机制[J]. 中国中药杂志, 2019, 44(1): 175-180. https://doi.org/10.19540/j.cnki.cjcmm.20180709.001
|
[38]
|
李红, 李珺莹, 吉彬, 等. 清热解毒汤治疗血热型寻常型银屑病及对Th17轴的影响[J]. 中国中西医结合皮肤性病学杂志, 2019, 18(1): 56-58.
|
[39]
|
杨登科. 基于IL-23/Th17免疫炎症轴探讨加味净屑饮治疗银屑病的临床疗效及免疫学机制[D]: [博士学位论文]. 南京: 南京中医药大学, 2021. https://doi.org/10.27253/d.cnki.gnjzu.2021.000910
|
[40]
|
张绚辉, 张玲, 曾海燕, 等. 重楼凉血克银方内服和外用对银屑病血热风盛证患者IL-23/IL-17轴的调节作用[J]. 环球中医药, 2020, 13(12): 2167-2169.
|
[41]
|
安月鹏, 闫景东, 杨素清. 蜈蚣败毒饮对银屑病小鼠皮损中Th17细胞主导通路相关因子基因表达影响的实验研究[J]. 时珍国医国药, 2020, 31(7): 1556-1559.
|
[42]
|
杨素清, 安月鹏. 蜈蚣败毒饮对银屑病转基因模型小鼠外周血中Th17细胞表达影响的研究[J]. 中国中西医结合皮肤性病学杂志, 2017, 16(6): 481-484.
|
[43]
|
安月鹏, 柏青松, 袁锐, 等. 蜈蚣败毒饮对转基因银屑病模型皮损IL-17和IL-23蛋白表达的影响及与皮损指数的相关性[J]. 中国皮肤性病学杂志, 2019, 33(5): 575-579. https://doi.org/10.13735/j.cjdv.1001-7089.201807195
|
[44]
|
黄港, 龚丽萍, 邱桂荣, 等. 透表和营解毒汤治疗银屑病小鼠模型的实验研究[J]. 时珍国医国药, 2020, 31(8): 1837-1840.
|
[45]
|
黄港, 龚丽萍, 邱桂荣, 等. 透表和营解毒方治疗血热型银屑病的临床研究[J]. 南京中医药大学学报, 2019, 35(4): 399-402. https://doi.org/10.14148/j.issn.1672-0482.2019.0399
|
[46]
|
张朋月, 杨波, 李咏梅, 等. 泻肝凉血解毒方对豚鼠银屑病模型IL-23/Th17轴的调节作用[J]. 中华中医药杂志, 2017, 32(7): 3217-3220.
|
[47]
|
李宁飞, 王燕, 赵京霞, 等. 活血解毒方对银屑病小鼠血管增殖以及炎症因子的干预作用[J]. 北京中医药大学学报, 2019, 42(4): 296-303.
|